Millennium Management
TRVI icon

Millennium Management’s Trevi Therapeutics TRVI Stock Holding History

Millennium Management’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.81M Buy
570,971
+745
+0.1% +$8.34K ﹤0.01% 2592
2025
Q4 		$7.14M Sell
570,226
-157,370
-22% -$1.82M ﹤0.01% 2637
2025
Q3 		$6.66M Buy
727,596
+570,352
+363% +$4.28M ﹤0.01% 2831
2025
Q2 		$860K Sell
157,244
-666,005
-81% -$4.14M ﹤0.01% 4522
2025
Q1 		$5.18M Buy
823,249
+642,830
+356% +$3.07M ﹤0.01% 2826
2024
Q4 		$743K Buy
180,419
+159,798
+775% +$512K ﹤0.01% 4432
2024
Q3 		$68.9K Buy
+20,621
New +$61.3K ﹤0.01% 5651
2024
Q1 		– Sell
-119,793
Closed -$161K – 6663
2023
Q4 		$161K Buy
+119,793
New +$181K ﹤0.01% 5235
2023
Q2 		– Sell
-59,628
Closed -$110K – 6694
2023
Q1 		$110K Sell
59,628
-97,996
-62% -$222K ﹤0.01% 5392
2022
Q4 		$304K Buy
157,624
+117,663
+294% +$232K ﹤0.01% 5097
2022
Q3 		$62K Sell
39,961
-26,222
-40% -$86K ﹤0.01% 6113
2022
Q2 		$186K Sell
66,183
-18,697
-22% -$45.9K ﹤0.01% 5673
2022
Q1 		$187K Sell
84,880
-36,612
-30% -$37.9K ﹤0.01% 5851
2021
Q4 		$95K Buy
+121,492
New +$128K ﹤0.01% 6277
2019
Q3 		– Sell
-12,300
Closed -$92K – 4566
2019
Q2 		$92K Buy
+12,300
New +$106K ﹤0.01% 3901

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return